RNA modulator (Remix Therapeutics/Janssen Pharmaceutica NV)

N/A

Report date: 2025/03/20 10:07:12
NME

Base Information

Drug NameRNA modulator (Remix Therapeutics/Janssen Pharmaceutica NV)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRemix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NVRemix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A